Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Operating expenses
Research and development	$ 108,671	$ 126,788	$ 486,759	$ 508,940
Selling, general and administrative	1,081,189	586,414	2,449,745	2,580,009
Total operating expenses	1,189,860	713,202	2,936,504	3,088,949
Loss from operations	(1,189,860)	(713,202)	(2,936,504)	(3,088,949)
Interest expense	(2,106)	(28,600)	(4,490)	(76,267)
Impairment loss on investment		(700,000)	(300,000)	(700,000)
Net loss	(1,191,966)	(1,441,802)	(3,240,994)	(3,865,216)
Deemed dividend on preferred stock	627,705		627,705
Net loss applicable to common stockholders	$ (1,819,671)	$ (1,441,802)	$ (3,868,699)	$ (3,865,216)
Net loss per share – Basic and diluted
Net loss per share – Basic and diluted	$ (0.14)	$ (0.12)	$ (0.30)	$ (0.36)
Weighted average common shares outstanding	12,902,549	12,261,971	12,818,232	10,730,928